Sarilumab COVID-19

Trial Identifier: EFC16844
Sponsor: Sanofi
Collaborator:
Regeneron Pharmaceuticals
Start Date: March 2020
Primary Completion Date: July 2020
Study Completion Date: September 2020
Condition: Coronavirus Infection

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
ARGENTINA Caba, ARGENTINA, C1180AAX
ARGENTINA Caba, ARGENTINA, 1430
ARGENTINA Caba, ARGENTINA, C1426AAM
BRAZIL Porto Alegre, BRAZIL, 90110-270
BRAZIL São José Do Rio Preto, BRAZIL, 15090-000
BRAZIL Sao Paulo, BRAZIL, 01327-001
BRAZIL Sao Paulo, BRAZIL, 04231-030
BRAZIL São Paulo, BRAZIL, 04321-120
CANADA Montreal, CANADA, H4A 3J1
CANADA Montreal, CANADA, H2X3E4
CANADA Toronto, CANADA, M4N3M5
CANADA Toronto, CANADA, M5G 2N2
CANADA Vancouver, CANADA, V5Z 1M9
CHILE Santiago, CHILE
CHILE Santiago, CHILE, 80004005
CHILE Santiago, CHILE, 750-0691
CHILE Talca, CHILE, 3460001
FRANCE Bordeaux Cedex, FRANCE, 33076
FRANCE Clamart, FRANCE, 92140
FRANCE La Roche Sur Yon Cedex 9, FRANCE, 85925
FRANCE Nantes, FRANCE, 44093
FRANCE Paris Cedex 18, FRANCE, 75877
FRANCE Strasbourg, FRANCE, 67098
FRANCE Suresnes, FRANCE, 92151
GERMANY Essen, GERMANY, 45147
GERMANY Köln, GERMANY, 50937
GERMANY Münster, GERMANY, 48149
Israel Ashdod, Israel, 7747629
ISRAEL Jerusalem, ISRAEL, 91120
ISRAEL Ramat Gan, ISRAEL, 52662
ITALY Milano, ITALY, 20132
ITALY Milano, ITALY, 20157
ITALY Milano, ITALY, 20122
ITALY Modena, ITALY, 41100
ITALY Parma, ITALY, 43100
ITALY Rozzano, ITALY, 20089
JAPAN Fuchu-Shi, JAPAN
JAPAN Iruma-Gun, JAPAN
JAPAN Kamakura-Shi, JAPAN
RUSSIAN FEDERATION Moscow, RUSSIAN FEDERATION, 123182
RUSSIAN FEDERATION Moscow, RUSSIAN FEDERATION, 111539
RUSSIAN FEDERATION Moscow, RUSSIAN FEDERATION, 129301
Spain Madrid, Spain, 28007
SPAIN Barcelona, SPAIN, 08035
SPAIN Barcelona, SPAIN, 08036
SPAIN Madrid, SPAIN, 28034
SPAIN Madrid, SPAIN, 28046